Edition:
United Kingdom

Dicerna Pharmaceuticals Inc (DRNA.OQ)

DRNA.OQ on NASDAQ Stock Exchange Global Select Market

12.85USD
11 Dec 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$12.85
Open
$12.87
Day's High
$13.11
Day's Low
$12.51
Volume
103,410
Avg. Vol
190,590
52-wk High
$17.96
52-wk Low
$6.81

Chart for

About

Dicerna Pharmaceuticals, Inc. is a ribonucleic acid (RNA) interference-based biopharmaceutical company. The Company operates in the segment of discovery, research and development of treatments based on its RNA interference (RNAi) technology platform. The Company is focused on the discovery and development of treatments for rare... (more)

Overall

Beta: 2.59
Market Cap(Mil.): $130.07
Shares Outstanding(Mil.): 20.84
Dividend: --
Yield (%): --

Financials

  DRNA.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -3.20 -- --
ROI: -76.78 0.29 15.02
ROE: -169.72 0.94 16.60

Eli Lilly makes bet on gene-silencing drug firm Dicerna

Eli Lilly and Co is spending $100 million for a stake in Dicerna Pharmaceuticals Inc as part of a licensing deal, making it the latest major drugmaker to bet on gene-silencing technology.

29 Oct 2018

Eli Lilly makes bet on gene-silencing drug firm Dicerna

* Lilly to pay Dicerna $100 mln upfront plus $100 mln for stake

29 Oct 2018

Earnings vs. Estimates